MIND MEDICINE (MINDMED) INC.

Analyst Reco. Mind Medicine (MindMed) Inc. Deutsche Boerse AG

Equities

MMQ

CA60255C8850

Real-time Estimate Tradegate Other stock markets 04:08:24 18/07/2024 pm IST			5-day change	1st Jan Change
7.643 ^EUR	-0.61%		+16.92%	+123.55%

17/07	Mind Medicine Says New Patent Secured for Investigational Anxiety Disorder Treatment MM120	MT
17/07	Mind Medicine Inc. Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mind Medicine Shares Fall After FDA Committee Votes Against Lykos Therapeutics' Psychedelic Drug	05/06	MT
Baird Starts Mind Medicine (MindMed) With Outperform Rating, $27 Price Target	29/05	MT
Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating	13/05	MT
Leerink Partners Starts Mind Medicine (MindMed) With Outperform Rating, $20 Price Target	15/04	MT
RBC Raises Price Target on Mind Medicine (MindMed) to $22 From $15, Keeps Outperform, Speculative Risk	08/03	MT
Roth MKM Raises Price Target on Mind Medicine to $36 From $25, Keeps Buy Rating	07/03	MT
RBC Lifts Price Target on Mind Medicine (MindMed) to $15 From $14, Notes Imminent Durability Data; Outperform, Speculative Risk Kept	29/02	MT
RBC Raises Price Target on Mind Medicine (MindMed) to $7 From $5, Maintains Outperform, Speculative Risk	04/23/04	MT
EF Hutton Initiates Mind Medicine at Buy With $21 Price Target	16/22/16	MT
Mind Medicine (MindMed) Initiated at Outperform by RBC With $5 Price Target, Speculative Risk Qualifier; Firm Sees 'Opportunity for Upside'	16/22/16	MT
HC Wainwright Adjusts Mind Medicine's Price Target to $75 from $5, Retains Buy Rating	21/22/21	MT
Oppenheimer Initiates Coverage on Mind Medicine With Outperform Rating, $3.50 Price Target	26/22/26	MT
HC Wainwright Adjusts Mind Medicine's Price Target to $5 From $10, Maintains Buy Rating	16/22/16	MT
Cantor Fitzgerald Starts Mind Medicine at Overweight With $3 Price Target	10/22/10	MT
Roth Capital Starts MindMed at Buy With $7 Price Target	04/22/04	MT
MIND MEDICINE MINDMED : HC Wainwright Starts MindMed at Buy With $10 Price Target	05/21/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Secure my Investments

fermer